Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | HCRTR2 | O43614 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16018387 | 0.87 | L3MBTL1 (0.40) | L3MBTL1SSTR4HTR2AHTR2C | |
| SCHEMBL12986075 | 0.86 | L3MBTL1 (0.42) | L3MBTL1HTR2AHTR2CHCRTR2 | |
| SCHEMBL13193196 | 0.84 | L3MBTL1 (0.40) | L3MBTL1SSTR4HTR2AHTR2C | |
| SCHEMBL16018378 | 0.83 | F2 (0.36) | HCRTR2 | |
| SCHEMBL458866 | 0.82 | SSTR4 (0.33) | SSTR4HCRTR2 | |
| SCHEMBL16018371 | 0.80 | SSTR4 (0.31) | SSTR4 | |
| SCHEMBL16018375 | 0.79 | TTK (0.35) | HCRTR2 | |
| SCHEMBL16018376 | 0.79 | TTK (0.34) | — | |
| SCHEMBL16018374 | 0.78 | L3MBTL1 (0.38) | L3MBTL1HTR2AHTR2C | |
| SCHEMBL12986964 | 0.73 | L3MBTL1 (0.45) | L3MBTL1HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2694500-B1 | SUBSTITUTED IMIDAZOPYRIDINES AND INTERMEDIATES THEREOF | Bayer Pharma AG (DE) | 2015-05-27 | — | — | EP | disclosed |
| US-20140255392-A1 | SUBSTITUTED IMIDAZOPYRIDINES AND INTERMEDIATES THEREOF | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-09-11 | — | — | US | disclosed |
| US-20140255392-A1 | SUBSTITUTED IMIDAZOPYRIDINES AND INTERMEDIATES THEREOF | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-09-11 | — | — | US | disclosed |
| US-8377641-B2 | Fluorescence quenching azo dyes, their methods of preparation and use | INTEGRATED DNA TECHNOLOGIES, INC. (US) | 2013-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140255392-A1 | SUBSTITUTED IMIDAZOPYRIDINES AND INTERMEDIATES THEREOF | FLT4, KDR, VEGFA | L3MBTL1 2809/4885SSTR4 855/4885HTR2A 2602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.